Biogen has announced plans to invest an additional $2bn in Research Triangle Park (RTP) in the US state of North Carolina.

Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as ...

Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as ...

Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date ...

Biogen will invest an additional $2 billion in its existing manufacturing in North Carolina, the drugmaker said on Monday, as ...

The Fortune 500 company based in Cambridge, Mass., opened its first campus in the Research Triangle Park in 1995.

Biogen Inc. is investing $2 billion in its North Carolina RTP site, expanding manufacturing amid tariff talks.

The biotech giant will grow its footprint at Research Triangle Park, while Premix opens a life sciences manufacturing plant ...

(Reuters) -Drugmaker Biogen said on Monday it will invest an additional $2 billion in its existing manufacturing footprint in ...

Since starting operations in North Carolina 30 years ago, Biogen has spent approximately $10 billion to bolster its ...

Biogen has unveiled plans to invest an additional $2bn in its existing manufacturing footprint in North Carolina, US. The ...

US biotech major Biogen has announced that it intends to invest an additional $2 billion in its existing manufacturing ...